Additional alterations in genes such as IDH1/2, IKZF1/3, RUNX1 and TP53 have been described in adult patients with CML‐CP and CML‐BP.30, 37, 38, 39. This evidence concerns the gene IKZF1 and chronic myelogenous leukemia, BCR-ABL1 positive.